altogen 5051,胰腺针对性体内转染试剂盒,PANCREAStargeted In Vivo Transfection_biogoods

altogen5051,胰腺针对性体内转染试剂盒,PANCREAS-targetedInVivoTransfection

货号：5031，NANOPARTICLEInVivoTransfectionKit,1.5mL(30injections)13370元

货号：5041，PEG-LiposomeInVivoTransfectionKit,1.5mL(30injections)13650元

货号：5051,PANCREAS-targetedInVivoTransfectionReagent-1.5mL(30injections)13930元

货号：5061LIVER-targetedInVivoTransfectionReagent-1.5mL(30injections)13930元

货号：5071KIDNEY-targetedInVivoTransfectionReagent-1.5mL(30injections)13930元

LIPID-basedInVivoTransfectionKitforRodents(Mouse,Cationiclipidliposome-basedsiRNAandplasmidDNAinvivodeliveryreagentEfficientdeliverytotheliver,pancreas,kidney,andcertaintumortypesviasystemicadmiNISTrationCompleteproductsupportinformationisavailableat:LIPIDInVivoTransfectionKit

Figure1.Systemicadministration(i.v.)ofLipid-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

Figure2.Intratumoraladministration(i.t.)ofLipid-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

POLYMER-basedInVivoTransfectionKitforRodents(Mouse,Rat)

Biodegradablepolymer-basedinvivoreagentEfficientdeliverytothelung,liver,kidney,andspleenviasystemicadministrationCompleteproductsupportinformationisavailableat:POLYMERInVivoTransfectionKit

Figure3.Systemicadministration(i.v.)ofPolymer-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

Figure4.Intratumoraladministration(i.t.)ofPolymer-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

NANOPARTICLE-basedInVivoTransfectionKitforRodents(Mouse,Rat)

Nanoparticle-basedreagentEfficientdeliverytotheheart,lung,liver,pancreas,kidney,andmultipletumortypesviasystemicadministrationCompleteproductsupportinformationisavailableat:NANOPARTICLEInVivoTransfectionKit

Figure5.Systemicadministration(i.v.)ofNanoparticle-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

Figure6.Intratumoraladministration(i.t.)ofNanoparticle-basedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

PEG-LiposomeInVivoTransfectionKitforRodents(Mouse,Rat)

PEGylatedliposomebasedreagentEfficientdeliverytothespleen,kidney,pancreas,liver,andmultipletumortypesviasystemicadministrationCompleteproductsupportinformationisavailableat:PEG-LiposomeInVivoTransfectionKit

Figure7.Systemicadministration(i.v.)ofLiposome-PEGbasedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

Figure8.Intratumoraladministration(i.t.)ofLiposome-PEGbasedInVivoreagentconjugatedwithsiRNAtargetingLaminA/CmRNAornon-silencingcontrolsiRNAfollowingtherecommendedprotocol.TissueswerecollectedandRNAisolated48hoursafterfirstinjection.SampleswereanalyzedbyqRT-PCRforLaminA/Cgeneexpressionlevels.RibosomalRNAlevelswereusedtonormalizetheLaminA/Cdata.Dataaremeans±SD(n=6).

Tissue-targetedInVivoTransfectionReagentsforRodents(Mouse,Rat):

LIVER-targetedinvivoreagentKIDNEY-targetedinvivoreagentPANCREAS-targetedinvivoreagent